Cantor Fitzgerald Maintains Overweight on Progyny, Raises Price Target to $35
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Cantor Fitzgerald analyst Sarah James maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the price target from $31 to $35.
Cantor Fitzgerald analyst Sarah James maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the price target from $31 to $35.